DEUTSCHE BANK AG\ - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 20 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$0100
-50.0%
0.00%
Q2 2017$0
-100.0%
200
-50.0%
0.00%
Q1 2017$1,0000.0%400
-38.1%
0.00%
Q3 2015$1,0006460.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,616,000$2,214,0000.28%
SABBY MANAGEMENT, LLC 345,524$473,0000.03%
Vantage Investment Advisors, LLC 6,500$9,0000.00%
IFP Advisors, Inc 15,800$22,0000.00%
BANK OF AMERICA CORP /DE/ 500$1,0000.00%
WELLS FARGO & COMPANY/MN 100$00.00%
DEUTSCHE BANK AG\ 200$00.00%
MORGAN STANLEY 1,220$1,0000.00%
BlackRock Inc. 635$1,0000.00%
Creative Planning 300$00.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders